For more publications: click google scholar

1. Minoh Ko, Kwangsoo Kim, Heeman Jang, Soomin Lee, Bumkyu Shin, Belong Cho, Seungyeon Kim‡, and Ha Young Jang‡
   Real-World Safety of Cyproheptadine-Based Appetite Stimulants: An Electronic Health Record-Based Retrospective Cohort Study in Adult Patients.
   J. Clin. Med. 2026, 15(1), 54;  (‡: Corresponding author)

2. Hee Yeon Kay†, Ha Young Jang†, In-Wha Kim, Jung Mi Oh. Ha Young Jang
   Pregnancy and neonatal outcomes after fetal exposure to statins among women with dyslipidemia: a nationwide cohort.
   Eur J Pediatr 184, 340 (2025). (†: Co-first)

3. Ha Young Jang, Boyoon Choi, In-Wha Kim, Hye Ryun Kang, Jung Mi Oh.
   Risk factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-analysis.
   JACI: In Practice. March 2025. DOI: 10.1016/j.jaip.2024.12.021  (2023 JCR 4/39, 9.0%)

4. Hee Yeon Kay†, Ha Young Jang†, In-Wha Kim, Jung Mi Oh.
   Fibrates and risk of congenital malformations: a nationwide cohort study in South Korea.
   Arch Gynecol Obstet. 2024 Oct;310(4):1967-1973; doi: 10.1007/s00404-023-07357-2. (†: Co-first)

5. Ha Young Jang, In-Wha Kim, and Jung Mi Oh.
   Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease versus Normal Kidney Function: A Nationwide Cohort Study in Korea.
   Pharmaceutics 2023, 15(10), 2394; https://doi.org/10.3390/pharmaceutics15102394

6. Ha Young Jang, Yon Su Kim, and Jung Mi Oh.
   Clinical Effectiveness of Renal Transplant Outpatient Pharmaceutical Care Services in Korea.
   Healthcare 2023, 11(18), 2597; https://doi.org/10.3390/healthcare11182597

7. Ha Young Jang, Hyun Kyung Lee, Chae Jeong Kim, Sung-Soo Yoon, In-Wha Kim, and Jung Mi Oh.
   Carfilzomib’s Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records.
   International Journal of Environmental Research and Public Health 19, no. 20: 13560. https://doi.org/10.3390/ijerph192013560

8. Ha Young Jang, Jung Mi Oh and In-Wha Kim.
   Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease.
   Frontiers in Neuroscience 16:989174. https://doi.org/10.3389/fnins.2022.989174

9. Ha Young Jang, In-Wha Kim and Jung Mi Oh.
   Using Real-World Data for Supporting Regulatory Decision Making: Comparison of Cardiovascular and Safety Outcomes of an Empagliflozin Randomized Clinical Trial Versus Real-World Data.
   Frontiers in Pharmacology 2022 August 13:928121. doi: 10.3389/fphar.2022.928121.

10. Ha Young Jang, Jihyeon Song, Jae Hyun Kim, Howard Lee, In-Wha Kim, Bongki Moon, and Jung Mi Oh.
    Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information.
    npj Digital Medicine 2022 June 11;5:88. doi: 10.1038/s41746-022-00639-0.  (2023 JCR 2/138, 0.01%)

11. Ha Young Jang, In-Wha Kim and Jung Mi Oh.
    Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.
    Front. Oncol. 2022 April 07;12:858855. doi: 10.3389/fonc.2022.858855 

12. Ha Young Jang, Jae Hyun Kim , Yun-Kyoung Song , Ju-Young Shin , Hae-Young Lee , Yong Min Ahn , Jung Mi Oh* and In-Wha Kim.
    Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study.
    Front. Pharmacol. 2020 Dec 10;11:594474. 

13. Ha Young Jang, Yun-Kyoung Song, Jae Hyun Kim, Myeong Gyu Kim, Nayoung Han, Hae-Young Lee, In-Wha Kim, Jung Mi Oh.
    Impact of depression on change in coronary heart disease risk status: the Korean Genome and Epidemiology Study (KoGES)
    Therapeutics and Clinical Risk Management 2018:14 1–8.